Lv32
370 积分 2024-10-21 加入
Epidermal growth factor receptor antagonists in colorectal cancer: emerging strategies for precision therapy
5个月前
已完结
An overview of recent advancements in small molecules suppression of oncogenic signaling of K-RAS: an updated review
5个月前
已完结
KRAS Inhibitors– yes but what next? Direct targeting of KRAS– vaccines, adoptive T cell therapy and beyond
5个月前
已完结
Blockade of mutant RAS oncogenic signaling with a special emphasis on KRAS
5个月前
已完结
KRAS G12C Game of Thrones, which direct KRAS inhibitor will claim the iron throne?
5个月前
已完结
Structure-based inhibitor design of mutant RAS proteins—a paradigm shift
5个月前
已完结
Targeting RAS mutants in malignancies: successes, failures, and reasons for hope
5个月前
已完结
Covalent inhibitors of the GTPase KRASG12C: a review of the patent literature
5个月前
已完结
Sotorasib with panitumumab in chemotherapy-refractory KRASG12C-mutated colorectal cancer: a phase 1b trial
5个月前
已完结
皖公网安备34019202002308
